1066 Stock Overview
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Shandong Weigao Group Medical Polymer Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.40 |
| 52 Week High | HK$7.70 |
| 52 Week Low | HK$3.60 |
| Beta | 0.45 |
| 11 Month Change | -10.20% |
| 3 Month Change | 9.73% |
| 1 Year Change | -41.80% |
| 33 Year Change | -59.78% |
| 5 Year Change | -53.44% |
| Change since IPO | -15.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1066 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -1.6% | -3.5% | -0.6% |
| 1Y | -41.8% | -39.2% | 9.6% |
Return vs Industry: 1066 underperformed the Hong Kong Medical Equipment industry which returned -39.2% over the past year.
Return vs Market: 1066 underperformed the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 1066 volatility | |
|---|---|
| 1066 Average Weekly Movement | 7.9% |
| Medical Equipment Industry Average Movement | 9.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 1066 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1066's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12,606 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables.
Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary
| 1066 fundamental statistics | |
|---|---|
| Market cap | HK$20.11b |
| Earnings (TTM) | HK$2.05b |
| Revenue (TTM) | HK$13.93b |
9.8x
P/E Ratio1.4x
P/S RatioIs 1066 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1066 income statement (TTM) | |
|---|---|
| Revenue | CN¥12.97b |
| Cost of Revenue | CN¥6.52b |
| Gross Profit | CN¥6.44b |
| Other Expenses | CN¥4.53b |
| Earnings | CN¥1.91b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.42 |
| Gross Margin | 49.69% |
| Net Profit Margin | 14.74% |
| Debt/Equity Ratio | 16.3% |
How did 1066 perform over the long term?
See historical performance and comparison